G Square Capital

General contacts

Investor type

Founded

2008

AUM

$3 999 M

Location

London, England, United Kingdom

Investment Ticket

$100+ m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

North America Europe

Investor profile last updated: 16 August, 2026

Profile

G Square Capital is a private equity firm headquartered in Europe, specializing in healthcare investments. Founded with a commitment to investing in mid-market healthcare companies, G Square is composed of a skilled team of professionals with extensive sector experience. Their expertise spans financial acumen, industry, and operational knowledge, allowing them to strategically manage their investment portfolio effectively.

G Square focuses on healthcare, targeting segments such as Medical Products, Healthcare IT (including software and telehealth), Healthcare Services, and Services to the Pharmaceutical Industry. They primarily invest in mid-market companies and manage substantial assets, using strategies such as buy-and-build to drive portfolio growth. Their geographical focus is primarily European, with a global reach.

Notable investments include Pharmacy2U - an online pharmacy service, Medadom - telemedicine solutions, Zahnarztzentrum.ch - dental care provider, Mikeva - elderly care services, and Artemis - medical diagnostic services. These investments establish G Square's strong presence in healthcare and reflect their strategic approach to value creation.

Industry

Consumer Products Healthcare Services Medical Devices Pharmaceuticals Software AI MedTech Life Sciences HealthTech Education Transportation Telecommunications Edtech

G Square Capital Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
G Square Capital I	Private Equity (PE)	Education Healthcare Services Transportation HealthTech	Series B Late Stage (Series C+)	Europe	$5-10 m	$250 M	March 2016
G Square Capital II	Private Equity (PE)	Education Healthcare Services Transportation	Series B Late Stage (Series C+)	Europe	$5-10 m	$380 M	February 2017
Pharmacy2U Continuation Fund		Consumer Products Healthcare Services Medical Devices Software Telecommunications AI Life Sciences HealthTech	Late Stage (Series C+)	North America Europe	$100+ m	—	September 2026
G Square Capital III	Private Equity (PE)	HealthTech Life Sciences MedTech AI Transportation Telecommunications Software Pharmaceuticals Medical Devices Healthcare Services Edtech Education Consumer Products	Series B Late Stage (Series C+)	North America Europe	$10-50 m	$554 M	January 2019

Contacts

Name

Title

Social Networks

Dr. Laurent Ganem Founder and CEO

Founder and CEO

l•••@•••

Antoni Soler Vicens Operating Partner & Advisory Board Member

Operating Partner & Advisory Board Member

a•••@•••

Upgrade to see contacts

vmsSIn7TLCtlYe3K vmsSIn7TLCtlYe3K

vmsSIn7TLCtlYe3K

[email protected]

vmsSIn7TLCtlYe3K vmsSIn7TLCtlYe3K

vmsSIn7TLCtlYe3K

[email protected]

vmsSIn7TLCtlYe3K vmsSIn7TLCtlYe3K

vmsSIn7TLCtlYe3K

[email protected]

Investment-team contacts for G Square Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about G Square Capital

Is G Square Capital a venture capital or private equity firm?

G Square Capital is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $100+ m.

Where is G Square Capital located?

G Square Capital is located in London, England, United Kingdom.

When was G Square Capital founded?

G Square Capital was founded in 2008.

What sectors and industries does G Square Capital invest in?

G Square Capital invests in companies and startups in Consumer Products, Healthcare Services, Medical Devices, Pharmaceuticals, Software, AI, MedTech, Life Sciences, HealthTech, Education, Transportation, Telecommunications, Edtech.

What is G Square Capital geographical focus of investments?

G Square Capital invests in companies and startups in North America, Europe.

At what stages of companies and startups does G Square Capital typically invest in?

G Square Capital invests in companies and startups at Series B, Late Stage (Series C+).

What is the usual amount of G Square Capital investment?

G Square Capital usually invests $100+ m on average.

What is the amount of assets of under management (AUM) for G Square Capital?

G Square Capital has around $3 999m assets under management.

When was G Square Capital last fund created?

G Square Capital last fund was created/launched in 2017-02-05

What are the contacts of G Square Capital?

G Square Capital can be reached through its website gsquarecapital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for G Square Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access G Square Capital data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query G Square Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the G Square Capital profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.